Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $23.80 in the last session, down -1.29% from day before closing price of $24.11. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 2.81 million shares were traded. ADMA stock price reached its highest trading level at $24.09 during the session, while it also had its lowest trading level at $23.2.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 55.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.41. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 15 ’25 when Grossman Adam S sold 21,000 shares for $21.46 per share. The transaction valued at 450,660 led to the insider holds 2,055,850 shares of the business.
Grossman Adam S sold 21,000 shares of ADMA for $397,320 on Mar 19 ’25. The President and CEO now owns 2,061,850 shares after completing the transaction at $18.92 per share. On Mar 19 ’25, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 84,000 shares for $18.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 5749341696 and an Enterprise Value of 5634208256. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.40, and their Forward P/E ratio for the next fiscal year is 24.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.98. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.31 while its Price-to-Book (P/B) ratio in mrq is 16.14. Its current Enterprise Value per Revenue stands at 13.212 whereas that against EBITDA is 38.321.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.57, which has changed by 2.5311573 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $6.50. The 50-Day Moving Average of the stock is 24.78%, while the 200-Day Moving Average is calculated to be 33.47%.
Shares Statistics:
According to the various share statistics, ADMA traded on average about 3.24M shares per day over the past 3-months and 4261160 shares per day over the past 10 days. A total of 236.62M shares are outstanding, with a floating share count of 230.23M. Insiders hold about 3.49% of the company’s shares, while institutions hold 86.19% stake in the company. Shares short for ADMA as of 1744675200 were 13256895 with a Short Ratio of 4.09, compared to 1741910400 on 15069973. Therefore, it implies a Short% of Shares Outstanding of 13256895 and a Short% of Float of 6.819999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
